Results 101 to 110 of about 21,091 (202)

Study of Mechanism of Lovastatin-induced Apoptosis in Oral Cancer Ca9-22 cells.

open access: yes, 2010
口腔癌為台灣男性十大癌症發生率的第五位。也是台灣地區年增率最高的癌症。儘管近幾年口腔癌在診斷及治技術上有改進,但病人五年存活率並未有顯著改善。因此須尋找新的治療與預防方法來改善整理存活率及生活品質。Lovastatin為膽固醇合成路徑HMG-CoA reductase的抑制劑,臨床上用以降低病人高血脂。近年研究指出,lovastatin可造成大腸癌、乳癌、及頭頸癌細胞凋亡,但其機制並不十分清楚。因此本研究以人類口腔癌細胞株Ca9-22來探討它對口腔癌細胞的影響。結果顯示,以lovastatin處理Ca9-
吳芳儀, Wu, Fang-Yi
core  

Lovastatin enhances the efficacy of TRAIL on subcutaneous brain tumor in mice models.

open access: yes, 2017
The nude mice bearing subcutaneous brain tumor were randomly divided into control group, lovastatin group (5 mg/Kg • day lovastatin), and lovastatin plus TRAIL group (5 mg/Kg • day lovastatin plus 200 ng TRAIL).
Wai Sang Poon (397929)   +8 more
core   +1 more source

Lovastatin treatment in glioblastoma cell lines promotes JNK pathway and inhibits MAPK/Erk pathway.

open access: yes, 2017
(A) The glioblastoma cell lines were treated with different concentrations of lovastatin. After treatment for 24 hours, the protein expression of JNK and Erk in the cell lines were detected by western blot. Representative western blots were shown.
Wai Sang Poon (397929)   +8 more
core   +1 more source

Effects of troglitazone and lovastatin on cell viability in ATC and fibroblast cells.

open access: yes, 2015
A. SW1736 human ATC cells were treated with the indicated concentrations of troglitazone and lovastatin for 24 h. B. WI-38 human fibroblast cells were cotreated with troglitazone (5 μM) and lovastatin (1 μM) for 24 h.
Li-Han Chin (700085)   +3 more
core   +1 more source

Lovastatin Suppresses Invasiveness of Anaplastic Thyroid Cancer Cells by Inhibiting Rho Geranylgeranylation and Rhoa/Rock Signaling

open access: yes, 2008
Lovastatin, a competitive inhibitor of 3-hydroxy-3- methylglutaryl (HMG)- CoA reductase, inhibits the conversion of mevalonate from HMG-CoA. Previously, we have reported that lovastatin treatment induced the occurrence of apoptosis and differentiation in
ZHONG, WEN-BIN;LIANG, YU-CHIH;WANG, CHIH-YUAN;CHANG, TIEN-CHUN;LEE, WEN-SEN   +1 more
core  

Anti-tumor effect of lovastatin on glioblastoma animal model and induction of DR5 expression by peri-tumoral administration of lovastatin in nude mice.

open access: yes, 2017
(A) The U87 MG cells were treated with different concentrations of lovastatin for 48 hours, and then cell cycle progression was analyzed by PI staining.
Wai Sang Poon (397929)   +8 more
core   +1 more source

PENGARUH Saccharomyces cerevisiae TERHADAP KADAR LOVASTATIN DALAM ANGKAK YANG DIHASILKAN DARI FERMENTASI BERAS OLEH Monascus purpureus JMBA

open access: yes, 2009
Fermented rice by Monascus purpureus, namely angkak, produces lovastatin. Lovastatin has been believed and studied as antihypercholesterolemic agent.
Novik Nurhidayat, Evi Triana
core   +1 more source

Lovastatin Reduces Stemness via Epigenetic Reprograming of BMP2 and GATA2 in Human Endometrium and Endometriosis

open access: yesCell Journal, 2017
Objective The stem cell theory in the endometriosis provides an advanced avenue of targeting these cells as a novel therapy to eliminate endometriosis.
Mehrdad Noruzinia, Mahdieh Taghizadeh
doaj  

Synergistic neutralization /inhibition of SEB-mediated T-cell activation by a combination of anti-SEB antibody and lovastatin.

open access: yes, 2013
(A) Anti-SEB Ch 82 M and lovastatin inhibit SEB action in BALB/c splenocytes. BALB/c splenocytes were cultured as outlined in materials and methods with the following additives: Medium alone, SEB alone, 100 ng/ml SEB; Hu IgG1κ+SEB, 10 µg/ml Human IgG1κ ...
David H. Margulies (339517)   +9 more
core   +1 more source

Anti-proliferative and apoptotic effects of Lovastatin on K562 Erthromyloidy cancer cell line

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2017
Background and Objective: Lovastatin is a HMG-CoA reductase inhibitor and used for the treatment of hypercholesterolemia. Inhibition of HMG-CoA reductase results in inhibiting the activity of the Ras proto-oncogene that has mutations in most cancers ...
M Vaezi, M Mohammadzadeh, Y Pazhang
doaj  

Home - About - Disclaimer - Privacy